Hospice Recertification SOAP Note for End-Stage COPD
For hospice recertification in end-stage COPD, the patient must continue to meet terminal prognosis criteria with life expectancy of 6 months or less if the disease runs its natural course, documented through progressive decline despite optimal therapy, severe functional impairment, and increasing healthcare utilization. 1
Subjective
Document the following key elements:
- Symptom progression: Worsening dyspnea at rest or with minimal exertion (mMRC score ≥3), increasing frequency and severity of symptoms despite maximal bronchodilator therapy 2
- Functional decline: Progression to bedbound or chair-bound status, inability to perform activities of daily living independently, increasing dependence on caregivers 1
- Recent exacerbations: Number of hospitalizations or emergency department visits in the past 6 months, frequency of acute exacerbations requiring systemic corticosteroids or antibiotics 1
- Weight loss: Unintentional weight loss or cachexia despite nutritional interventions 1
- Quality of life: Patient and family perception of disease burden, goals of care discussions, acceptance of terminal prognosis 1
Objective
Critical clinical indicators to document:
- Pulmonary function: FEV1 <30% predicted or FEV1 <50% with chronic respiratory failure (if available from recent testing) 1
- Oxygen requirements: Continuous supplemental oxygen use with PaO2 ≤55 mmHg or SaO2 ≤88% on room air, or evidence of cor pulmonale 1
- Vital signs: Resting tachycardia (>100 bpm), tachypnea (>25 breaths/min), evidence of respiratory distress 1
- Physical examination: Use of accessory muscles, pursed-lip breathing, cyanosis, peripheral edema suggesting right heart failure, cachexia (BMI <21 kg/m²) 1
- Hypercapnia: PaCO2 >50 mmHg on arterial blood gas if available 1
- Recent hospitalizations: Document dates and reasons for admissions in the past 6 months 3
Assessment
Medicare hospice eligibility criteria for COPD require documentation of:
- Severe chronic lung disease with FEV1 <30% predicted (post-bronchodilator) OR
- Disabling dyspnea at rest, poorly responsive to bronchodilators, resulting in decreased functional capacity (bed-to-chair existence, fatigue, cough) 1
- Progressive disease documented by increasing visits to emergency department or hospitalizations for pulmonary infections and/or respiratory failure 1
- Hypoxemia at rest on supplemental oxygen (PaO2 ≤55 mmHg or SaO2 ≤88%) OR hypercapnia (PaCO2 ≥50 mmHg) 1
- Right heart failure secondary to pulmonary disease (cor pulmonale) 1
Additional supporting factors that strengthen terminal prognosis:
- Unintentional progressive weight loss >10% over 6 months 1
- Resting tachycardia >100 bpm 1
- Decline in functional status with increasing dependence in most or all ADLs 1
- Significant comorbidities (cardiac disease, cachexia, depression) 1
The American Thoracic Society acknowledges that predicting 6-month mortality in COPD is challenging and that these criteria do not guarantee death within 6 months, but Medicare will continue coverage if patients still meet enrollment criteria beyond 6 months 1. The BODE index, while prognostic over 12-52 months, has not been validated for 6-month mortality prediction required for hospice 1.
Plan
Continue hospice services with focus on:
- Symptom management: Optimize comfort with opioids for refractory dyspnea, anxiolytics for anxiety, bronchodilators for comfort (not cure) 4
- Oxygen therapy: Continue supplemental oxygen for comfort, not to prolong life 1
- Interdisciplinary team involvement: Registered nurse for symptom assessment and coordination, social worker and chaplain for psychosocial and spiritual support, home health aide for personal care 1
- Advance care planning: Confirm DNR/DNI status, discuss preferences for management of future exacerbations, clarify that patient understands hospice provides comfort care only 1
- Caregiver support: Assess caregiver burden, offer respite care as needed 1
- Monitoring: Regular nursing visits to assess symptom control, functional status, and caregiver needs 1
Common pitfall to avoid: Do not delay hospice recertification based solely on survival beyond initial 6-month period—patients can remain in hospice as long as they continue to meet clinical criteria for terminal illness 1. The physician certifying hospice eligibility does not "guarantee" death within 6 months but rather certifies that prognosis is more likely than not less than 6 months if disease runs its natural course 1.
Recertification statement: Based on continued decline in functional status, persistent severe symptoms despite optimal palliative therapy, ongoing oxygen dependence, and [specific clinical findings], this patient continues to meet criteria for hospice care with a terminal prognosis of 6 months or less if the disease runs its natural course.